03/05/2019 Transcatheter Heart Valves Greece 2019 | K. Papadopoulos | Lessons from the MITRA-FR and COAPT studies; How should we quantify MR?

info_icon

 

Δηλώνω υπεύθυνα ότι είμαι γιατρός ή εξασκώ παραϊατρικό επάγγελμα |

I hereby declare that I am a medical professional  

 

Συμφωνώ | Άκυρο

467 VIEWS EXPANDCOLLAPSE

Share

46,844 total
707 live
467 video
17,088 photo
Views:

3/5Αίθουσα Banquet Hall, MAICC -
18:30-20:00 JOINT SESSION II
Πρόεδροι: G. Athanassopoulos,G. Giamouzis,A. Trikas
18:30-18:45 Exercise-stress echocardiography and effort intolerance in asymptomatic/symptomatic degenerative mitral regurgitation
D. Klettas
18:45-19:00 Mitraclip vs. PASCAL. Similarities and differences
K. Spargias
19:00-19:15 Lessons from the MITRA-FR and COAPT studies; How should we quantify MR?
K. Papadopoulos
19:15-19:30 Percutaneous mitral repair after failed open surgery
S. Kar
19:30-19:45 Who are the best candidates for experimental TMVR in 2019?
N. Kleiman
19:45-20:00 Lessons from an International Registry on Transcatheter Tricuspid Thearapies
F. Maisano


Το 8o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών θα μεταδοθεί ζωντανά στο Livemedia
3 - 4 Μαίου 2019. Το Συνέδριο διοργανώνεται από το Διαγνωστικό Θεραπευτήριο Κέντρο Αθηνών Υγεία και θα πραγματοποιηθεί στο Μέγαρο Μουσικής Αθηνών.

Για περισσότερες πληροφορίες πατήστε εδώ.

 
Sort by Date | Views
G. Pattakos | Latest TAVR Randomized Trials... 379
M. Vavuranakis | High-Quality TAVR: Does... 341
S. Prapas | The selection of SAVR devices... 373
P. Dedeilas | Rapid Deployment Surgical... 370
WELCOME NOTES 358
A. Chalapas | CT Imaging of Bicuspid Aortic... 372
N. Van Mieghem | TAVR will be the treatment... 430
D. Angouras | Most Bicuspid aortic valves... 354
S. Kodali | Strokes After TAVR and SAVR:... 344
R. Mehran | What’s Holding Back Cerebral... 310
M. Οto | TAVR in the patient with significant... 310
A. Halapas | Live in a Box | TAVR Session... 361
L. Papavasileiou | Incidence, predictors... 379
N. Kleiman | Is paravalvular regurgitation... 321
S. Kapadia | A Selective versus Routine... 292
M. Οto | Management of Coronary Disease... 321
M. Chirssoheris | Live in a Box | TAVI Session... 326
A. Katsaros | Impact of valvular heart disease... 346
A. Patrianakos | Patient-prosthesis mismatch... 344
E. Anagnostou | Moderate aortic stenosis... 509
G. Pattakos | Minimally invasive surgery... 347
S. Kodali | In hospital mortality after... 290
G. Giamouzis - G. Karatasakis | JOINT SESSON... 358
S. Kapadia | TAVR for All? New insights... 298
J. Kisslo | Defining Secondary Mitral Regurgitation:... 326
S. Kar | Mitraclip for Functional Mitral... 307
D. Klettas | Exercise-stress echocardiography... 535
K. Spargias | Mitraclip vs. PASCAL. Similarities... 387
K. Papadopoulos | Lessons from the MITRA-FR... 467
S. Kar | Percutaneous mitral repair after... 314
N. Kleiman | Who are the best candidates... 338
F. Maisano | Lessons from an International... 369
M. Chrissoheris | Echocardiographic evaluation... 345
A. Pitsis | Mitral Valve-in-valve and valve-in-ring... 309
J. Velianou | Results of valve-in-MAC (mitral... 306
S. Kar | Currently enrolling TMVR and TTVR... 343
F. Maisano | You can’t beat safety and simplicity:... 326
N. Baikoussis - K. Bellos - E. Petropoulou... 314
K. Papadopoulos | Live in a box Mitraclip... 332
V. Voudris | A growing conundrum: Coronary... 340
N. Van Mieghem | Mechanisms of coronary... 306
N. Bouboulis | Hybrid beating heart bypass... 301
A. Manginas | Guidelines and classification... 308
R. Mehran | TAVR plus/minus AFib and/or... 319
G. Dangas | The Spectrum of Leaflet Thrombosis... 295
Discussion | TAVI Session IV – Avoiding Pitfalls 325
G. Pattakos |Live in a Box | TAVI Session... 297
M. Kasel | To crack or not to crack? The... 328
K. Spargias | Supra-annular TAVR devices.... 322
J. Velianou | To split or not to split?... 341
M. Kasel | The rapid emergence of transcaval... 290
P. Dardas | TAVR in the decompensated patient... 204
K. Dimitriadis | Transcatheter Heart Valves... 203
Discussion | TAVR Session V – Dealing with... 198
A. Οto - Transcatheter Heart Valves Greece... 198
S. Kapadia | Transcatheter Heart Valves Greece... 204
Σ.Παττακός | Transcatheter Heart Valves Greece... 179
K. Spargias | How far should we push the... 244
M. Chrissoheris | Live-in-a-box TAVR | TAVR... 206
A. Holzamer | The ACCURATE Neo TAVR system.... 198
L. Michalis | The PORTICO TAVR system. Program... 194
V. Martzaklis | Medtronic Structural Heart... 204
M. Kasel | What to expect in the near future... 173
L. Michalis | A Deep Dive Into TAVR Cost-Effectiveness... 180
M. Kasel | TAVR device selection in the... 185
J. Kisslo | Three-Dimensional Echocardiography... 201
F. Maisano | Patient selection for transcatheter... 211
M. Chrissoheris | Advanced echocardiography... 192
K. Spargias | Technical tips and tricks... 212
V. Ninios | An often Challenging MitraClip... 178
A. Tzifa | Transcatheter valve-in-valve... 249
A. Pitsis | Minimally invasive surgery for... 209
S. Pattakos | The Structural Heart and Valve... 188
C. Arampatzis | My best and/or my worst... 196
J. Iakovou | My best and/or my worst Structural... 188
G. Katsimagklis | My best and/or my worst... 186
D. Nikas | My best and/or my worst Structural... 194
K. Perreas | My best and/or my worst Structural... 192
K. Spiliotopoulos | My best and/or my worst... 190
K. Triantafyllou | My best and/or my worst... 172
D. Tsikaderis | My best and/or my worst... 180
I. Zarifis | My best and/or my worst Structural... 190
Closing of the conference 186